The product was discarded, therefore no product failure analysis can be conducted and device malfunction cannot be confirmed. if additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.The manufacturing record evaluation (mre) cannot be conducted because no lot number was provided by the customer.(b)(4).
|
It was reported that a male patient underwent an ablation procedure with a thermocool® smart touch® sf uni-directional navigation catheter and suffered ventricular fibrillation requiring external defibrillation and extracorporeal membrane oxygenation (ecmo) and hypoxic-ischaemic encephalopathy.The patient had a planned ventricular tachycardia (vt) ablation for recurrent icd shocks.Mapping was done utilizing a large agilis sheath, a pentaray navigational eco catheter and a thermocool® smart touch® sf uni-directional navigation catheter.At the end of the mapping phase, the patient developed slow vt (130bpm).Then, when mapping the left ventricle (lv) with the thermocool® smart touch® sf uni-directional navigation catheter, a faster vt was mechanically induced that developed to ventricular fibrillation (vt).External defibrillation was performed.Patient returned to sinus for several before going to fast vt/vf again.Electrical storm couldn¿t be terminated.Hospital internal emergency team was called and installed ecmo on the operating table to stabilize circulation and decreased pump function of heart.Patient¿s condition worsened and had glascow coma scale of 4 points.The patient was breathing by himself; however, reacted inadequate to stimulation and developed severe brain damage.Extended hospitalization was required as a result of the adverse event.No biosense webster, inc.Product malfunctions were reported.Physician¿s opinion regarding the cause of the adverse event is that it was patient condition related.
|